|
MFF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.883000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.475030E-03 |
| Normal-vs-Stage2 |
7.831600E-02 |
| Normal-vs-Stage3 |
1.185990E-01 |
| Normal-vs-Stage4 |
7.694400E-01 |
| Stage1-vs-Stage2 |
7.448800E-01 |
| Stage1-vs-Stage3 |
4.802600E-01 |
| Stage1-vs-Stage4 |
6.106400E-02 |
| Stage2-vs-Stage3 |
8.105200E-01 |
| Stage2-vs-Stage4 |
1.898570E-01 |
| Stage3-vs-Stage4 |
2.172600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.986600E-04 |
| Normal-vs-AfricanAmerican |
3.603400E-01 |
| Normal-vs-Asian |
7.505000E-01 |
| Caucasian-vs-AfricanAmerican |
6.060000E-02 |
| Caucasian-vs-Asian |
1.363200E-01 |
| AfricanAmerican-vs-Asian |
4.835600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.627590E-04 |
| Normal-vs-Female |
7.152000E-01 |
| Male-vs-Female |
1.109900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.780400E-02 |
| Normal-vs-Extreme_Weight |
5.797500E-04 |
| Normal-vs-Obese |
1.886560E-01 |
| Normal-vs-Extreme_Obese |
9.618000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.059000E-01 |
| Normal_Weight-vs-Obese |
4.816000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.119600E-01 |
| Extreme_Weight-vs-Obese |
1.045640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.492200E-01 |
| Obese-vs-Extreme_Obese |
5.822200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.364400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.946200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.399220E-04 |
| Normal-vs-Age(81-100Yrs) |
8.175900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.189160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.016500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.279900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.545900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.281600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.936400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.795800E-03 |
| Normal-VS-Type2 PRCC |
6.36819999999538E-05 |
| Normal-VS-KIRP CIMP |
9.068000E-02 |
| Normal-VS-Unclassified PRCC |
3.677600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.924300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.084200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.318000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.193350E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.100300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.443500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.419010E-03 |
| Normal-vs-N1 |
7.874800E-01 |
| Normal-vs-N2 |
7.523800E-01 |
| N0-vs-N1 |
1.106430E-02 |
| N0-vs-N2 |
3.311200E-01 |
| N1-vs-N2 |
7.628000E-01 |
|
|
